Following a request from the European Commission in August 2010, ECDC assessed the epidemiological history of Human T-lymphotropic Virus (HTLV) across the world, possible risks of HTLV transmission through transplantation of human tissues and cells, and possible measures to prevent such transmission.
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.
Following a request by the Romanian government, ECDC conducted a second follow-up country visit to Romania covering HIV, sexually transmitted infections (STIs) and hepatitis B and C from 11–13 May 2011.
Following a request by the Estonian government, ECDC performed a follow-up country visit to Estonia covering HIV and sexually transmitted infections (STIs) from 11–13 October 2010.
An organ perfusion solution known as Viaspan® has been identified as being potentially contaminated with Bacillus cereus. Viaspan®, which is used to preserve organs prior to transplantation, is distributed to a number of countries around the world.According to ECDC's risk assessment, the likelihood of contamination and risk of infection in recipients or potential recipients of organ transplants preserved in Viaspan® solution produced after July 2011 appears to be low, based on the negative results of microbiological cultures in solution samples and the absence of reported patient cases to date. Nevertheless, vigilance is recommended to mitigate the risk.
Following a request from the European Commission in August 2010, ECDC assessed the epidemiological history of Human T-lymphotropic Virus (HTLV) across the world, possible risks of HTLV transmission through transplantation of human tissues and cells, and possible measures to prevent such transmission.
The risk of Foot and Mouth disease being transmitted to humans visiting affected areas is extremely low, if consumption of pasteurised milk, dairy products or unprocessed meat from infected animals and direct contact with such animals is avoided.
The purpose of this risk assessment is to evaluate the risk to the citizens of Europe of CPE spread through patient mobility and to assess the effectiveness of infection control methods to stop the spread of CPE within healthcare institutions.